Azerbaijan vs Uganda: Access to anti-retroviral drugs, male
Azerbaijan
80.0%
in 2024
Uganda
81.0%
in 2024
Azerbaijan rank
47th
Uganda rank
46th
Access to anti-retroviral drugs, male over time
- Azerbaijan
- Uganda
How they compare
Uganda currently reports 81.0% against 80.0% in Azerbaijan, a difference of 1.0%.
Across all 24 years both countries report, Uganda has been ahead every year.
Azerbaijan ranks 47th and Uganda ranks 46th of 141 countries.
Uganda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 7.3% | 6.7% | Uganda |
| 2010s | 23.7% | 44.3% | 20.6% | Uganda |
| 2020s | 65.2% | 75.6% | 10.4% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Azerbaijan or Uganda?
- Uganda, at 81.0% against 80.0% in Azerbaijan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Azerbaijan and Uganda?
- 1.0%, with Uganda ahead.
- How many years of comparable data are there for Azerbaijan and Uganda?
- 24 years are reported by both, from 2000 to 2024.
- How do Azerbaijan and Uganda rank globally for access to anti-retroviral drugs, male?
- Azerbaijan ranks 47th and Uganda ranks 46th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.